PMC:7696151 / 39385-39592
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"1151","span":{"begin":102,"end":105},"obj":"Chemical"}],"attributes":[{"id":"A1151","pred":"tao:has_database_id","subj":"1151","obj":"MESH:D006886"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"inability of the dosing regimens currently in use to achieve the blood concentration required for the HCQ antiviral activity. Initially, based on physiological pharmacokinetic models, Yao et al. recommended "}